Swine Flu News and Research

RSS

Swine Flu or influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.

WHO will meet to decide if H1N1 has peaked

The WHO will convene a meeting of its emergency committee later this month to assess whether H1N1 (swine flu) has peaked, Keiji Fukuda, the special adviser to the WHO's director general for pandemic influenza, said Thursday, Bloomberg reports.

15 Feb 2010

New method may help assess impact and cost-effectiveness of flu vaccination campaigns

A new study (doi:10.1016/j.vaccine.2010.01.002), published by Elsevier this month in Vaccine (http://www.elsevier.com/locate/vaccine) describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options.

10 Feb 2010

Health officials encourage caution, despite H1N1 case decline

As the number of new H1N1 (swine flu) infections worldwide drops, U.S. health officials on Friday cautioned the virus continues to circulate and can still be deadly, Reuters reports. According to the WHO, H1N1 remains the dominant strain worldwide, but there are reports of the recent emergence of the seasonal flu in Africa and China, according to the news agency.

10 Feb 2010

Triple-S Management reports consolidated revenues of $516.9 million for fourth-quarter 2009

Triple-S Management Corporation, the largest managed care company in Puerto Rico, today announced consolidated revenues of $516.9 million and operating income of $34.2 million for the three months ended December 31, 2009.

9 Feb 2010

Majority of Americans believe flu outbreak is over; levels of concern continue to decline

The latest poll from researchers at the Harvard School of Public Health (HSPH) shows that almost half of Americans believe the H1N1 flu outbreak is over (44%), and levels of concern about getting sick with the virus continue to decline.

6 Feb 2010

New York Times examines WHO process for getting H1N1 vaccines to countries in need

The New York Times examines the WHO's role as a "clearinghouse" for getting the H1N1 (swine flu) vaccine to lower income nations. Though H1N1 has died down in North America and many wealthier nations "are trying to get rid of their [vaccine] surpluses," the virus continues to circulate in regions of North Africa, Central Asia and Eastern Europe, according to the newspaper.

3 Feb 2010

New device to eliminate pathogenic bacteria and viruses

A revolutionary new device is being launched today with the technology to eradicate 99.9999% of pathogenic airborne and surface bacteria and viruses.

3 Feb 2010

Study identifies key demographic and psychological factors that predict protective behaviour during pandemics

A study that looked at how people behave during pandemics has identified key demographic and psychological factors that may predict protective behaviours. The study is published online today, 30th January 2010, in the British Journal of Health Psychology.

30 Jan 2010

NewsRx publishes new encyclopedia on vaccines

NewsRx, a 25-year-old publisher and international news organization headquartered in Atlanta, has published a new encyclopedia on vaccines -- Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals.

28 Jan 2010

African vaccine maker plans to increase production capacity sevenfold by 2013

Biovac Institute, a South African vaccine maker, said Monday that it is working with other major pharmaceutical firms to increase its annual capacity sevenfold to 35 million doses by 2013, Reuters reports.

28 Jan 2010

Recipients of the 2010 Media Awards for Health Reporting announced

The Canadian Nurses Association (CNA) and the Canadian Medical Association (CMA) today announced the recipients of the 2010 Media Awards for Health Reporting, Canada's premier health journalism awards.

27 Jan 2010

WHO rejects accusations it mishandled H1N1, updates worldwide stats

WHO spokesperson Gregory Hartl on Monday rejected accusations that the organization miscategorized H1N1 (swine flu) as a pandemic, calling such accusations "irresponsible," the Associated Press/Washington Post reports. "WHO also dismissed claims it colluded with drug companies to bring economic benefit to the industry by playing up the danger of the new H1N1 [swine flu] influenza strain," the news service writes.

27 Jan 2010

UCI finding could complicate quest to eradicate deadly disease in humans

Chimpanzees were known to carry the parasite Plasmodium reichenowi, but most scientists assumed the two parasites had existed separately in humans and chimpanzees for the last 5 million years.

20 Jan 2010

WHO, CDC issue H1N1 updates

Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.

19 Jan 2010

WHO official rejects claims agency overhyped threat of H1N1

Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.

18 Jan 2010

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

moksha8 and BioCryst today announced that moksha8 has been granted approval from COFEPRIS (The Federal Commission for the Protection against Sanitary Risk) in Mexico for the importation and use of peramivir in patients with influenza associated with the 2009 H1N1 influenza A strain.

13 Jan 2010

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.

12 Jan 2010

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

VaxInnate Corporation today announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.

12 Jan 2010

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

American Red Cross urges Americans to get vaccinated against H1N1 virus

The H1N1 (swine) flu virus is still prevalent across the nation, and the American Red Cross encourages everyone to get vaccinated against the virus, now that the vaccine is widely available.

12 Jan 2010

Swine Flu News and Research

Further Reading

WHO will meet to decide if H1N1 has peaked

New method may help assess impact and cost-effectiveness of flu vaccination campaigns

Health officials encourage caution, despite H1N1 case decline

Triple-S Management reports consolidated revenues of $516.9 million for fourth-quarter 2009

Majority of Americans believe flu outbreak is over; levels of concern continue to decline

New York Times examines WHO process for getting H1N1 vaccines to countries in need

New device to eliminate pathogenic bacteria and viruses

Study identifies key demographic and psychological factors that predict protective behaviour during pandemics

NewsRx publishes new encyclopedia on vaccines

African vaccine maker plans to increase production capacity sevenfold by 2013

Recipients of the 2010 Media Awards for Health Reporting announced

WHO rejects accusations it mishandled H1N1, updates worldwide stats

UCI finding could complicate quest to eradicate deadly disease in humans

WHO, CDC issue H1N1 updates

WHO official rejects claims agency overhyped threat of H1N1

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

American Red Cross urges Americans to get vaccinated against H1N1 virus

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News